Literature DB >> 6328416

Immunoglobulin gene 'remnant' DNA--implications for antibody gene recombination.

E Selsing, J Voss, U Storb.   

Abstract

Many immunoglobulin (Ig)-producing cells retain the DNA that separates Ig variable (V) and constant (C) region genes in the germline. This "remnant" DNA must be moved during the recombination process that joins V and C genes via a joining (J) segment. We have analyzed remnant DNAs in several Ig-producing cell lines. The nucleotide sequences of kappa (kappa) light chain remnant DNAs indicate close relationships to V-J joining. We find fused V kappa and J kappa recognition sequences in five remnant DNAs, suggesting reciprocal relationships to the fused V kappa and J kappa segments produced by V-J joining. However, of sixteen plasmacytoma remnant DNAs analyzed, all involve only recombination with J kappa l. Thus, in most cell lines, remnant DNAs are not directly reciprocal to recombined kappa-genes. On the other hand, our analyses of some myelomas do indicate indirect relationships between remnant DNAs and kappa-genes. Our results suggest that multiple steps of DNA recombination occur during Ig-gene rearrangement. Because remnant DNA joining sites do not exhibit the flexibility that has been observed in Ig-gene V-J joining, our findings also suggest that the joining mechanism may involve endonuclease, exonuclease and ligase activities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328416      PMCID: PMC318828          DOI: 10.1093/nar/12.10.4229

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  Sequences at the somatic recombination sites of immunoglobulin light-chain genes.

Authors:  H Sakano; K Hüppi; G Heinrich; S Tonegawa
Journal:  Nature       Date:  1979-07-26       Impact factor: 49.962

2.  A kappa-immunoglobulin gene is formed by site-specific recombination without further somatic mutation.

Authors:  J G Seidman; E E Max; P Leder
Journal:  Nature       Date:  1979-08-02       Impact factor: 49.962

Review 3.  Transformation of immature lymphoid cells by Abelson murine leukemia virus.

Authors:  D Baltimore; N Rosenberg; O N Witte
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

Review 4.  Restriction endonucleases.

Authors:  R J Roberts
Journal:  CRC Crit Rev Biochem       Date:  1976-11

5.  Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes.

Authors:  H Sakano; R Maki; Y Kurosawa; W Roeder; S Tonegawa
Journal:  Nature       Date:  1980-08-14       Impact factor: 49.962

6.  A mutant immunoglobulin light chain is formed by aberrant DNA- and RNA-splicing events.

Authors:  J G Seidman; P Leder
Journal:  Nature       Date:  1980-08-21       Impact factor: 49.962

7.  Functional and non-functional joining in immunoglobulin light chain genes of a mouse myeloma.

Authors:  W Altenburger; M Steinmetz; H G Zachau
Journal:  Nature       Date:  1980-10-16       Impact factor: 49.962

8.  An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH.

Authors:  P Early; H Huang; M Davis; K Calame; L Hood
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

9.  Novel kappa light-chain gene rearrangements in mouse lambda light chain-producing B lymphocytes.

Authors:  J Durdik; M W Moore; E Selsing
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

10.  Activity of multiple light chain genes in murine myeloma cells producing a single, functional light chain.

Authors:  F W Alt; V Enea; A L Bothwell; D Baltimore
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

View more
  17 in total

Review 1.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Molecular cloning of a rat chromosome putative recombinogenic sequence homologous to the hepatitis B virus encapsidation signal.

Authors:  H Aoki; K Kajino; Y Arakawa; O Hino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Double recombination of a single immunoglobulin kappa-chain allele: implications for the mechanism of rearrangement.

Authors:  R M Feddersen; B G Van Ness
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

4.  Reciprocal recombination products of VK-JK joining reactions in human lymphoid cell lines.

Authors:  S M Deev; G Combriato; H G Klobeck; H G Zachau
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

5.  Direct evidence for intrastrand DNA inversion of kappa immunoglobulin gene segments in two murine plasmacytomas.

Authors:  R Feddersen; B Van Ness
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

6.  Nonproductive kappa immunoglobulin genes: recombinational abnormalities and other lesions affecting transcription, RNA processing, turnover, and translation.

Authors:  D E Kelley; L M Wiedemann; A C Pittet; S Strauss; K J Nelson; J Davis; B Van Ness; R P Perry
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

7.  Linking of the human immunoglobulin VK and JKCK regions by chromosomal walking.

Authors:  H G Klobeck; F J Zimmer; G Combriato; H G Zachau
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

8.  Active lambda and kappa antibody gene rearrangement in Abelson murine leukemia virus-transformed pre-B cell lines.

Authors:  D M Persiani; J Durdik; E Selsing
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

9.  Corrective recombination of mouse immunoglobulin kappa alleles in Abelson murine leukemia virus-transformed pre-B cells.

Authors:  R M Feddersen; B G Van Ness
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

10.  Aberrant recombination events in B cell lines derived from a kappa-deficient human.

Authors:  J Stavnezer; O Kekish; D Batter; J Grenier; I Balazs; E Henderson; B J Zegers
Journal:  Nucleic Acids Res       Date:  1985-05-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.